Phase I evaluation of a fully human anti-alphav integrin monoclonal antibody (CNTO 95) in patients with advanced solid tumors. (Q40453891)
Jump to navigation
Jump to search
scientific article published on April 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I evaluation of a fully human anti-alphav integrin monoclonal antibody (CNTO 95) in patients with advanced solid tumors. |
scientific article published on April 2007 |
Statements
Phase I evaluation of a fully human anti-alphav integrin monoclonal antibody (CNTO 95) in patients with advanced solid tumors (English)
Saifee A Mullamitha
Nhuan C Ton
Alan Jackson
Peter J Julyan
Caleb Roberts
Gio A Buonaccorsi
Yvonne Watson
Karen Davies
Sue Cheung
Lynn Hope
Jeremy Lawrance
Mark P Saunders
Mihaela C Munteanu
Marian T Nakada
Jeffrey A Nemeth
Hugh M Davis
Qun Jiao
Uma Prabhakar
Zhihui Lang
Robert E Corringham
Robert A Beckman